annual CFO:
-$46.91M+$81.60M(+63.50%)Summary
- As of today (September 17, 2025), AVDL annual cash flow from operations is -$46.91 million, with the most recent change of +$81.60 million (+63.50%) on December 31, 2024.
- During the last 3 years, AVDL annual CFO has risen by +$30.40 million (+39.33%).
- AVDL annual CFO is now -155.65% below its all-time high of $84.29 million, reached on December 31, 2015.
Performance
AVDL Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
$12.87M+$21.10M(+256.33%)Summary
- As of today (September 17, 2025), AVDL quarterly cash flow from operations is $12.87 million, with the most recent change of +$21.10 million (+256.33%) on June 1, 2025.
- Over the past year, AVDL quarterly CFO has increased by +$30.86 million (+171.52%).
- AVDL quarterly CFO is now -49.15% below its all-time high of $25.31 million, reached on March 31, 2017.
Performance
AVDL quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$6.08M+$30.86M(+124.53%)Summary
- As of today (September 17, 2025), AVDL TTM cash flow from operations is $6.08 million, with the most recent change of +$30.86 million (+124.53%) on June 1, 2025.
- Over the past year, AVDL TTM CFO has increased by +$118.85 million (+105.39%).
- AVDL TTM CFO is now -84.64% below its all-time high of $39.58 million, reached on September 30, 2017.
Performance
AVDL TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
AVDL Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +63.5% | +171.5% | +105.4% |
| 3 y3 years | +39.3% | +173.4% | +106.5% |
| 5 y5 years | -22.4% | +265.5% | +117.5% |
AVDL Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +63.5% | at high | +133.5% | at high | +104.6% |
| 5 y | 5-year | -22.4% | +63.5% | at high | +133.5% | at high | +104.6% |
| alltime | all time | -155.7% | +63.5% | -49.1% | +133.5% | -84.6% | +104.6% |
AVDL Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $12.87M(-256.3%) | $6.08M(-124.5%) |
| Mar 2025 | - | -$8.23M(-190.5%) | -$24.78M(-46.4%) |
| Dec 2024 | -$46.91M(-63.5%) | $9.10M(-218.8%) | -$46.26M(-43.6%) |
| Sep 2024 | - | -$7.65M(-57.5%) | -$81.98M(-27.3%) |
| Jun 2024 | - | -$17.99M(-39.4%) | -$112.78M(-14.3%) |
| Mar 2024 | - | -$29.70M(+11.6%) | -$131.64M(-0.4%) |
| Dec 2023 | -$128.51M(+82.8%) | -$26.62M(-30.8%) | -$132.17M(+8.2%) |
| Sep 2023 | - | -$38.45M(+4.3%) | -$122.15M(+38.2%) |
| Jun 2023 | - | -$36.86M(+21.9%) | -$88.41M(+28.0%) |
| Mar 2023 | - | -$30.23M(+82.0%) | -$69.09M(-5.2%) |
| Dec 2022 | -$70.30M(-9.1%) | -$16.61M(+252.7%) | -$72.90M(-5.5%) |
| Sep 2022 | - | -$4.71M(-73.1%) | -$77.13M(-16.9%) |
| Jun 2022 | - | -$17.53M(-48.5%) | -$92.76M(+8.6%) |
| Mar 2022 | - | -$34.05M(+63.4%) | -$85.39M(+14.2%) |
| Dec 2021 | -$77.31M(+58.6%) | -$20.84M(+2.5%) | -$74.76M(+1.0%) |
| Sep 2021 | - | -$20.34M(+100.0%) | -$74.05M(+13.7%) |
| Jun 2021 | - | -$10.17M(-56.6%) | -$65.13M(+3.8%) |
| Mar 2021 | - | -$23.41M(+16.3%) | -$62.74M(+23.1%) |
| Dec 2020 | -$48.73M(+27.2%) | -$20.13M(+76.2%) | -$50.97M(+30.6%) |
| Sep 2020 | - | -$11.42M(+46.9%) | -$39.02M(+12.2%) |
| Jun 2020 | - | -$7.78M(-33.2%) | -$34.79M(+22.7%) |
| Mar 2020 | - | -$11.64M(+42.2%) | -$28.34M(-25.2%) |
| Dec 2019 | -$38.33M(-53.7%) | -$8.18M(+13.8%) | -$37.91M(-28.4%) |
| Sep 2019 | - | -$7.19M(+440.7%) | -$52.97M(-18.7%) |
| Jun 2019 | - | -$1.33M(-93.7%) | -$65.18M(-21.7%) |
| Mar 2019 | - | -$21.21M(-8.8%) | -$83.20M(+4.0%) |
| Dec 2018 | -$82.72M(-596.4%) | -$23.24M(+19.8%) | -$80.00M(+11.5%) |
| Sep 2018 | - | -$19.40M(+0.2%) | -$71.73M(+32.7%) |
| Jun 2018 | - | -$19.35M(+7.5%) | -$54.07M(+108.6%) |
| Mar 2018 | - | -$18.01M(+20.3%) | -$25.92M(-249.1%) |
| Dec 2017 | $16.66M(-11.8%) | -$14.97M(+761.0%) | $17.39M(-56.1%) |
| Sep 2017 | - | -$1.74M(-119.8%) | $39.58M(+8.7%) |
| Jun 2017 | - | $8.79M(-65.3%) | $36.40M(+55.9%) |
| Mar 2017 | - | $25.31M(+250.4%) | $23.35M(+26.8%) |
| Dec 2016 | $18.90M(-77.6%) | $7.22M(-246.8%) | $18.41M(+64.5%) |
| Sep 2016 | - | -$4.92M(+15.5%) | $11.19M(-30.5%) |
| Jun 2016 | - | -$4.26M(-120.9%) | $16.11M(-20.9%) |
| Mar 2016 | - | $20.37M(-19.4%) | $20.37M(+15.2%) |
| Dec 2015 | $84.29M(-893.9%) | - | - |
| Mar 2015 | - | $25.27M(-544.0%) | $17.67M(-276.8%) |
| Dec 2014 | -$10.62M | -$5.69M(-262.7%) | -$10.00M(-15.0%) |
| Sep 2014 | - | $3.50M(-164.7%) | -$11.77M(-24.7%) |
| Jun 2014 | - | -$5.41M(+125.5%) | -$15.62M(-2.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | -$2.40M(-67.9%) | -$16.00M(-24.5%) |
| Dec 2013 | -$20.68M(-10.6%) | -$7.46M(+2020.9%) | -$21.20M(+54.3%) |
| Sep 2013 | - | -$351.70K(-93.9%) | -$13.74M(+2.6%) |
| Jun 2013 | - | -$5.79M(-23.8%) | -$13.39M(-15.6%) |
| Mar 2013 | - | -$7.60M(-8.2%) | -$15.87M(-11.6%) |
| Dec 2012 | -$23.14M(+124.1%) | - | - |
| Jun 2012 | - | -$8.27M(+80.4%) | -$17.96M(+75.1%) |
| Mar 2012 | - | -$4.58M(+37.8%) | -$10.25M(+2.6%) |
| Dec 2011 | -$10.32M(+89.2%) | -$3.33M(+87.2%) | -$10.00M(+43.7%) |
| Sep 2011 | - | -$1.78M(+213.2%) | -$6.96M(+34.3%) |
| Jun 2011 | - | -$567.20K(-86.9%) | -$5.18M(+12.3%) |
| Mar 2011 | - | -$4.33M(+1407.1%) | -$4.62M(+1507.1%) |
| Dec 2010 | -$5.46M(-166.6%) | -$287.30K(-87.6%) | -$287.30K(-98.6%) |
| Dec 2009 | $8.20M(-209.2%) | - | - |
| Dec 2008 | -$7.51M(-61.0%) | - | - |
| Dec 2007 | -$19.24M(-35.5%) | -$2.32M(-34.9%) | -$20.35M(+12.9%) |
| Sep 2007 | - | -$3.56M(-49.0%) | -$18.03M(+24.6%) |
| Jun 2007 | - | -$6.98M(-6.7%) | -$14.47M(-18.7%) |
| Mar 2007 | - | -$7.49M(-27.4%) | -$17.79M(-49.2%) |
| Dec 2006 | -$29.83M(+53.8%) | - | - |
| Jun 2006 | - | -$10.31M(-1.1%) | -$35.00M(+47.7%) |
| Mar 2006 | - | -$10.42M(+24.5%) | -$23.70M(+27.8%) |
| Dec 2005 | -$19.39M(+367.2%) | -$8.37M(+41.6%) | -$18.55M(+29.2%) |
| Sep 2005 | - | -$5.91M(-693.3%) | -$14.36M(+29.0%) |
| Jun 2005 | - | $996.00K(-118.9%) | -$11.13M(-11.4%) |
| Mar 2005 | - | -$5.27M(+26.1%) | -$12.56M(+202.7%) |
| Dec 2004 | -$4.15M(-136.2%) | -$4.18M(+56.2%) | -$4.15M(-125.3%) |
| Sep 2004 | - | -$2.68M(+518.1%) | $16.38M(-14.0%) |
| Jun 2004 | - | -$433.00K(-113.8%) | $19.05M(+22.8%) |
| Mar 2004 | - | $3.14M(-80.8%) | $15.52M(+35.3%) |
| Dec 2003 | $11.47M(+30.8%) | $16.35M(>+9900.0%) | $11.47M(-335.5%) |
| Sep 2003 | - | $0.00(-100.0%) | -$4.87M(0.0%) |
| Jun 2003 | - | -$3.97M(+338.3%) | -$4.87M(+438.3%) |
| Mar 2003 | - | -$905.00K(+201.7%) | -$905.00K(+201.7%) |
| Dec 2002 | $8.77M(-415.1%) | - | - |
| Dec 2001 | -$2.78M(-50.5%) | - | - |
| Dec 2000 | -$5.62M(+32.6%) | - | - |
| Dec 1999 | -$4.24M(-48.2%) | - | - |
| Dec 1998 | -$8.19M(-8.0%) | - | - |
| Mar 1998 | - | -$300.00K(-160.0%) | -$300.00K(-160.0%) |
| Dec 1997 | -$8.90M(+111.9%) | - | - |
| Dec 1996 | -$4.20M | - | - |
| Mar 1996 | - | $500.00K | $500.00K |
FAQ
- What is Avadel Pharmaceuticals plc annual cash flow from operations?
- What is the all time high annual CFO for Avadel Pharmaceuticals plc?
- What is Avadel Pharmaceuticals plc annual CFO year-on-year change?
- What is Avadel Pharmaceuticals plc quarterly cash flow from operations?
- What is the all time high quarterly CFO for Avadel Pharmaceuticals plc?
- What is Avadel Pharmaceuticals plc quarterly CFO year-on-year change?
- What is Avadel Pharmaceuticals plc TTM cash flow from operations?
- What is the all time high TTM CFO for Avadel Pharmaceuticals plc?
- What is Avadel Pharmaceuticals plc TTM CFO year-on-year change?
What is Avadel Pharmaceuticals plc annual cash flow from operations?
The current annual CFO of AVDL is -$46.91M
What is the all time high annual CFO for Avadel Pharmaceuticals plc?
Avadel Pharmaceuticals plc all-time high annual cash flow from operations is $84.29M
What is Avadel Pharmaceuticals plc annual CFO year-on-year change?
Over the past year, AVDL annual cash flow from operations has changed by +$81.60M (+63.50%)
What is Avadel Pharmaceuticals plc quarterly cash flow from operations?
The current quarterly CFO of AVDL is $12.87M
What is the all time high quarterly CFO for Avadel Pharmaceuticals plc?
Avadel Pharmaceuticals plc all-time high quarterly cash flow from operations is $25.31M
What is Avadel Pharmaceuticals plc quarterly CFO year-on-year change?
Over the past year, AVDL quarterly cash flow from operations has changed by +$30.86M (+171.52%)
What is Avadel Pharmaceuticals plc TTM cash flow from operations?
The current TTM CFO of AVDL is $6.08M
What is the all time high TTM CFO for Avadel Pharmaceuticals plc?
Avadel Pharmaceuticals plc all-time high TTM cash flow from operations is $39.58M
What is Avadel Pharmaceuticals plc TTM CFO year-on-year change?
Over the past year, AVDL TTM cash flow from operations has changed by +$118.85M (+105.39%)